Literature DB >> 6671796

Therapy of anaerobic infections.

T D Wilkins, S E West.   

Abstract

Anaerobic bacteria commonly cause soft tissue infections in humans, usually as a result of trauma. Although the susceptibility of some species to antibiotics can be predicted reasonably well, many clinical laboratories can do susceptibility tests more easily than they can correctly identify anaerobes. The broth-disk test is the simplest test for clinical laboratories, and a new standardized MIC method is now available for research laboratories. Several types of experimental anaerobic infections can be initiated in animals, and these infections have been used to test the efficacy of therapeutic regimens. Metronidazole was the most effective, and clindamycin was also very active. Elimination of the anaerobic component of abscesses may be sufficient therapy; it may be possible to ignore the facultative organisms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6671796     DOI: 10.1007/bf01645299

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Influence of pencillinase production by strains of Bacteroides melaninogenicus and Bacteriodes oralis on pencillin therapy of an experimental mixed anaerobic infection in mice.

Authors:  A S Hackman; T D Wilkins
Journal:  Arch Oral Biol       Date:  1976       Impact factor: 2.633

2.  Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice.

Authors:  C B Walker; T D Wilkins
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

3.  Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria.

Authors:  T D Wilkins; T Thiel
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

4.  Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.

Authors:  V L Sutter; A L Barry; T D Wilkins; R J Zabransky
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

5.  Macrolide, lincosamide, streptogramin and tetracycline transferable resistance in the Bacteroides fragilis group.

Authors:  G Privitera; G Botta; M Sebald
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

6.  Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing.

Authors:  J Wüst; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

7.  Experimental intra-abdominal abscesses in rats: development of an experimental model.

Authors:  W M Weinstein; A B Onderdonk; J G Bartlett; S L Gorbach
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

Review 8.  Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis.

Authors:  J G Bartlett; T J Louie; S L Gorbach; A B Onderdonk
Journal:  Rev Infect Dis       Date:  1981 May-Jun
  8 in total
  2 in total

Review 1.  The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy.

Authors:  R Wise
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

2.  Penetration of ceftazidime into human pancreas.

Authors:  B Drewelow; K Koch; C Otto; A Franke; A K Riethling
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.